| Patents for C07K 14 - Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof (291,526) |
|---|
| 11/24/2005 | US20050260154 G-CSF analog compositions and methods |
| 11/24/2005 | US20050260131 Pharmaceuticals for enhanced delivery to disease targets |
| 11/24/2005 | US20050259483 Genes and polypeptides relating to prostate cancers |
| 11/24/2005 | US20050259281 Method, apparatus and computer program for transforming digital colour images |
| 11/24/2005 | CA2852855A1 Genetic polymorphisms associated with liver fibrosis methods of detection and uses thereof |
| 11/24/2005 | CA2837792A1 Genetic polymorphisms associated with liver fibrosis methods of detection and uses thereof |
| 11/24/2005 | CA2826522A1 Genetic polymorphisms associated with liver fibrosis methods of detection and uses thereof |
| 11/24/2005 | CA2820168A1 Identification of surface-associated antigens for tumor diagnosis and therapy |
| 11/24/2005 | CA2573918A1 Cross-linkable glycoproteins and methods of making the same |
| 11/24/2005 | CA2567301A1 Therapeutic, prophylactic and diagnostic agents for hepatitis b |
| 11/24/2005 | CA2566632A1 Polypeptides from non-typeable haemophilus influenzae |
| 11/24/2005 | CA2566619A1 Compositions comprising addl receptor syngap |
| 11/24/2005 | CA2566292A1 Mucin3 egf-like domains |
| 11/24/2005 | CA2566257A1 Genetic polymorphisms associated with vascular diseases, methods of detection and uses thereof |
| 11/24/2005 | CA2565872A1 T-cell death-inducing epitopes |
| 11/24/2005 | CA2565414A1 O-linked glycoforms of polypeptides and method to manufacture them |
| 11/24/2005 | CA2565368A1 Oral formulations comprising bone morphogenetic proteins for treating metabolic bone diseases |
| 11/24/2005 | CA2565070A1 Anti-ctgf agents for the treatment of pancreatic cancer |
| 11/24/2005 | CA2564934A1 Recombinant lentiviral vector for expression of a flaviviridae protein and applications thereof as a vaccine |
| 11/24/2005 | CA2564126A1 Method of inducing immunity against stratum corneum chymotrytic enzyme |
| 11/24/2005 | CA2563796A1 Diagnostic assay for trypanosoma cruzi infection |
| 11/24/2005 | CA2563671A1 Identification of surface-associated antigens for tumor diagnosis and therapy |
| 11/24/2005 | CA2563434A1 Methods for modifying plant characteristics |
| 11/24/2005 | CA2563396A1 Method of using adenoviral vectors to induce an immune response |
| 11/24/2005 | CA2563311A1 Inducible dimerization of growth factor receptors for treating cancer |
| 11/24/2005 | CA2562715A1 Methods of using and compositions comprising immunomodulatory compounds for the treatment and management of myelodysplastic syndromes |
| 11/24/2005 | CA2560981A1 Polymer-based sustained release device |
| 11/23/2005 | EP1598425A1 Modified Vaccinia Ankara virus variant |
| 11/23/2005 | EP1598420A2 Pharmaceutical compositions and utilization thereof particularly for the treatment of neurodegenerative diseases |
| 11/23/2005 | EP1598416A1 Method for producing L-amino acid |
| 11/23/2005 | EP1598370A2 Methods of preparation and composition of peptide constructs useful for treatment of autoimmune and transplant related host versus graft conditions |
| 11/23/2005 | EP1598369A1 Antibody and use thereof |
| 11/23/2005 | EP1598368A1 Anti-pci neutralizing antibody |
| 11/23/2005 | EP1598367A1 Modified coagulation factors with enhanced stability and their derivatives |
| 11/23/2005 | EP1598366A1 Somatostatin analogues |
| 11/23/2005 | EP1598365A1 Protection of endogenous therapeutic peptides |
| 11/23/2005 | EP1598364A1 Chimerical soluble hyper IL-11 receptor and use thereof |
| 11/23/2005 | EP1598363A1 Protein regulating the concentration of calcium in endoplasmic reticulum |
| 11/23/2005 | EP1598362A2 Chlamidya trachomatis antigens |
| 11/23/2005 | EP1598077A1 Use of the neurotoxic component of botulinum toxins for the treatment of a spastic muscle |
| 11/23/2005 | EP1598075A1 Process for the isolation and / or purification of proteins |
| 11/23/2005 | EP1597580A2 Diagnostics and therapeutics for diseases associated with human endothelial differentiation, sphingolipid g-protein-coupled receptor 5 (edg5) |
| 11/23/2005 | EP1597557A2 A method for diagnosis and prognosis of multiple sclerosis |
| 11/23/2005 | EP1597383A2 Variants of cytochrome c and methods of diagnosis of thrombocytopenia |
| 11/23/2005 | EP1597381A2 Production of modified glycoproteins having multiple antennary structures |
| 11/23/2005 | EP1597378A2 Production of multimeric proteins |
| 11/23/2005 | EP1597370A1 Rhesus carcino embryonic antigen, nucleotides encoding same, and uses thereof |
| 11/23/2005 | EP1597369A1 Use of caspase enzymes for maturation of engineered recombinant polypeptide fusions |
| 11/23/2005 | EP1597368A2 Vaccines derived from epithelial cell mucin muc-1 |
| 11/23/2005 | EP1597367A1 Glycorpotein antigen sima135 expressed in metastatic human tumor cells |
| 11/23/2005 | EP1597360A2 Antiplasmin cleaving enzyme |
| 11/23/2005 | EP1597352A2 A novel human g-protein coupled receptor, hgprbmy23, expressed highly in kidney |
| 11/23/2005 | EP1597350A2 Nucleic acid molecules, polypeptides, antibodies and compositions containing same useful for treating and detecting influenza virus infection |
| 11/23/2005 | EP1597349A2 Methods of screening for trpm5 modulators |
| 11/23/2005 | EP1597348A2 Conserved and specific streptococcal genomes |
| 11/23/2005 | EP1597279A1 Peptide inhibitors of thrombin as potent anticoagulants |
| 11/23/2005 | EP1597278A2 Polyethylene glycol modified interferon compositions and methods of use thereof |
| 11/23/2005 | EP1597277A2 Hypoallergenic der p 1 and der p 3 proteins from dermatographoides pteronyssinus |
| 11/23/2005 | EP1597275A2 Secreted chlamydia polypeptides, polynucleotides coding therefor, therapeutic and diagnostic uses thereof |
| 11/23/2005 | EP1597274A2 Hsp60 from arthrobacter |
| 11/23/2005 | EP1597273A2 Soluble ctla4 polypeptides and methods for making the same |
| 11/23/2005 | EP1597272A2 Lepidoptera voltage-gated calcium channels |
| 11/23/2005 | EP1597271A2 Peptides directed against antibodies, which cause cold-intolerance, and the use thereof |
| 11/23/2005 | EP1597268A2 Water soluble animal muscle protein product |
| 11/23/2005 | EP1597265A2 Glycosolated enkephalin agents |
| 11/23/2005 | EP1596879A1 Use of kahalalide compounds for the manufacture of a medicament for the treatment of psoriasis |
| 11/23/2005 | EP1596871A2 T cell regulation |
| 11/23/2005 | EP1596811A2 Compositions and methods to modulate immune and inflammatory responses |
| 11/23/2005 | EP1596807A2 Immune regulation based on the targeting of early activation molecules |
| 11/23/2005 | EP1596806A2 Compositions and methods for treating cancer using igsf9 and liv-1 |
| 11/23/2005 | EP1596804A2 SOLUBLE FcyR FUSION PROTEINS AND METHODS OF USE THEREOF |
| 11/23/2005 | EP1392864A4 Compositions and methods for gender sorting |
| 11/23/2005 | EP1381628B1 Inflammation-specific peptides and the uses thereof |
| 11/23/2005 | EP1322751B1 Glutaryl cephalosporin amidase from pseudomonas diminuta bs-203 |
| 11/23/2005 | EP1287026B1 Leishmania antigens for use in the therapy and diagnosis of leishmaniasis |
| 11/23/2005 | EP1226264B1 Cell lines and constructs useful in production of e1-deleted adenoviruses in absence of replication competent adenovirus |
| 11/23/2005 | EP1185628B1 Isolation of a human retrovirus |
| 11/23/2005 | EP1155029A4 Bk beta subunits of slo family potassium channels |
| 11/23/2005 | EP1153130B1 Polymorphic human gaba a receptor alpha-6 subunit |
| 11/23/2005 | EP1082409B1 RESISTANCE IN PLANTS TO INFECTION BY ssDNA VIRUS USING INOVIRIDAE VIRUS ssDNA-BINDING PROTEIN, COMPOSITIONS AND METHODS OF USE |
| 11/23/2005 | EP1078007B1 Verotoxin b subunit for immunization |
| 11/23/2005 | EP1039930B1 ADJUVANTED VACCINE COMPRISING AN ANTIGEN FROM STREPTOCOCCUS PNEUMONIAE AND A CpG OLIGONUCLEOTIDE |
| 11/23/2005 | EP1000164B1 Induction of male sterility in plants by expression of high levels of streptavidin |
| 11/23/2005 | EP0958357B1 Novel method for testing the differentiation status in pancreatic cells of a mammal |
| 11/23/2005 | EP0939817B1 High-affinity interleukin-4 muteins |
| 11/23/2005 | EP0837939B1 Mammalian apoptosis inhibitor protein gene family, primers, probes and detection methods |
| 11/23/2005 | EP0835305B1 Cytokine that induces apoptosis |
| 11/23/2005 | EP0770129B1 Zinc finger protein derivatives and methods therefor |
| 11/23/2005 | EP0732934B1 Long-acting injection suspensions of an lhrh analogue and a process for their preparation |
| 11/23/2005 | EP0662128B1 Methods and compositions for controlling translation of hcv proteins |
| 11/23/2005 | CN1701293A Systems and methods for authenticating a user to a web server |
| 11/23/2005 | CN1701119A Methods for increasing the production of a recombinant polypeptide from a host cell |
| 11/23/2005 | CN1701079A Genes and polypeptides relating to chronic myeloid leukemia |
| 11/23/2005 | CN1701078A Genes and polypeptides relating to prostate cancers |
| 11/23/2005 | CN1700930A Methods and reagents relating to inflammation and apoptosis |
| 11/23/2005 | CN1699420A B-chain modified monomer quick-acting insulin and method for preparing same |
| 11/23/2005 | CN1699419A Human blood high density lipoprotein and its preparation method and use |
| 11/23/2005 | CN1699418A A simulated epitope peptide of MUC1 mucoprotein and its encoding DNA and use thereof |
| 11/23/2005 | CN1699417A Human blood high density lipoprotein and its preparation method and use |
| 11/23/2005 | CN1699416A Glycine-riched protein and active fragment and use thereof |